Joshua Halpern

Joshua Halpern,
MD

Radiation Oncologist, Prostate & Bladder Cancer

2270 Kimball St #101, Brooklyn, NY 11234

Statement

Prostate cancer is the second most common cancer in America, ranking only behind skin cancer – and it will affect one out of every nine American males during their lifetime. In fact, research has shown that more than half of all men in the United States over the age of 70 are now living with some form of prostate cancer.


Types and Typical Victims of Prostate Cancer


Most forms of the disease progress slowly and are highly treatable. However, prostate cancer is deadly, and it kills quickly. Once a patient’s cancer reaches its fourth and final stage, however, the five-year survival rate is is a dismal 29%.


Two groups of males are particularly susceptible to prostate cancer: those over the age of 70, and African-American men. The latter are 1.6 times more likely to develop the disease than white males, and 2.6 times more likely to experience prostate cancer than Asian-American men.


Prostate Cancer: Symptoms and Diagnosis


Most alarming is that many patients with the disease don’t experience any symptoms. Experts like Dr. Joshua Halpern of the Accord Physicians Group recommends that all males, especially African-Americans, be screened regularly for prostate cancer by a doctor once they reach age 40.


Dr. Halpern is a certified radiation oncologist who received his oncology training at Roswell Park Cancer Institute and MD Anderson Cancer Center, the nation’s leading cancer treatment center. He has treated all forms of cancer for more than 40 years, and has had hands-on experience with thousands of prostate cancer patients. He explains the processes that urologists use to diagnose and confirm the disease.


The first step in the rigorous process of diagnosing prostate cancer is to draw blood and conduct a Prostate-Specific Antigen (PSA) test. PSA is a protein naturally produced in men’s prostate glands, and abnormally-high PSA levels may indicate the presence of prostate cancer, although they could also be signs of other prostate issues such as inflammation or enlargement.


Normal levels of the protein are usually in the 0.0-4.0 range. But once the PSA levels are greater than 4.0, Dr. Halpern says, the normal procedure is to recommend a biopsy during which a small section of prostate tissue is removed and examined for signs of cancer.


Dr. Halpern explains that if the biopsy results are positive for prostate cancer, the next step is to consult a radiation oncologist. At Accord Physicians Group, he and his fellow physicians  work in close collaboration to decide on a course of action.


Prostate Cancer Treatment 


Dr. Halpern is one of the first oncologists to use a form of treatment, called Image Guided Radiation Therapy (IGRT). It is completely non-invasive, and involves 45 ten-minute sessions during which a short beam of radiation is targeted directly at the inside of the prostate. “Published reports on IMRT/IGRT radiation, with careful administration, have shown the best results and the lowest toxicity,” says Dr. Halpern. “In our experience, tumor control is very high and tolerance to our treatment is nearly universal.”


Excellent results of the cancer control as well as the low side effect profile are due to the fascinating physics of this radiation therapy.  The plan that's used to deliver the radiotherapy is individually and specifically designed for each person.  It take into account the differences that all people have in relation to their size, muscle to body fat ratio and the physical size of the prostate and the surrounding organs.  It also takes into consideration any anatomic changes that may have occurred due to previous pelvic surgeries, trauma and anatomic abnormalities such as inguinal hernias.   After this detailed plan is complete, the treatment therapy begins.  On a daily basis during the therapy, the equipment and the technician who delivers the radiation performs a daily minute adjustment to precisely deliver the radiotherapy despite differences such as contents of the colon and the amount of urine in the bladder at the time of treatment. 


Once IGRT therapy has been completed, the patient usually exhibits dramatically lower PSA levels, indicating that the cancer is either gone or is fully in remission. In the occasional case when PSA levels remain extremely high, the oncologist will meet regularly with the patient to track progress and discuss options. All medical personnel at Accord Physicians Group have received special training to ensure the patient’s comfort during and after treatment, and to respectfully and compassionately assist him with the emotional effects of a cancer diagnosis and treatment.


Accord Physicians Group and Prostate Cancer


Dr. Halpern states, “Over the last ten years we treated hundreds of prostate cancer patients at Accord Physicians.”  He elaborates, that “Our cure and remission rates are between 93 and 95% over this ten year period, and our side effect profile is well below the national average.”


Dr. Halpern urges all men – particularly African-American men over the age of 40 – to be screened regularly for prostate cancer.
 

Specialty

Radiation Oncology

Board Certifications

American Board of Radiology
American Board of Radiology, Radiation Oncology, 1988
Clinical Oncology, Israel, 1981
Radiation Therapy, Israel, 1981
NY State Medical License
NY State Medical License

Professional Memberships

Pediatric Oncology Group, Co-Investigator 1984 - 1987
Radiation Therapy and Oncology Group
Radiation Therapy and Oncology Group, Co-Investigator 1984 - 1987
American Medical Association 1985 - present
American Society of Therapeutic Radiation Oncology
American Society of Therapeutic Radiation Oncology 1985 - present
American Society of Clinical Oncology
American Society of Clinical Oncology 1984 - present
New York Academy of Science
New York Academy of Science 1984 - present
Gilbert Fletcher Society 1987 - present
Phi Lambda Kappa Medical Society
Phi Lambda Kapa Medical Society 1994 - present

Education & Training

Hadassah University
Hadassah Medical School
Hebrew University, Jerusalem, Israel
1965 - 1971 - M.D.
Meyer Hospital
Meir Hospital, Internship
Kfar Saba, Israel
1971 - 1972
Hadassah University
Hadassah University, Residency
Jerusalem Department of Hematology
1976 - 1977
Hadassah University
Hadassah University, Residency
Jerusalem Departments of Radiation and Clinical Oncology
1977 - 1980
Hadassah University
Hadassah University, Residency
Jerusalem Department of Internal Medicine
1980 - 1981
Roswell Park Memorial Institute
Roswell Park Memorial Institute
Buffalo NY Fellowship in GYN Radiotherapy and Brachytherapy
1983 - 1984
MD Anderson Cancer Center
MD Anderson Cancer Center
Houston TX Senior Fellowship in Radiation Therapy of Breast and Lung Tumors
1987 - 1988

Awards and Publications

American Medical Association
AMA Physician Recognition Award 1985 - 2005

University Appointments

Roswell Park Memorial Institute

SUNY at Buffalo. Roswell Park Memorial Institute
Clinical Assistant Professor, 1984 - 1987

SUNY Health Science Center

SUNY Health Science Center at Brooklyn. NY
Clinical Associate Professor, 1991 - 1995

UMDNJ University Hospital

UMDNJ-University Hospital. Newark. NJ 
Associate Professor of Clinical Radiology, 1995 - 1998

Cornell Medical School NY

Cornell Medical School NY. NY
Associate Professor of Clinical Radiology, 1998 - present

Other Professional Positions and Major Visiting Appointments

Academic Proctorships

1980 - 1981 - Dr. Shimon Schlanger: Thesis on Antitumoral Immunomodulatory effects of Tuftsin. Department of Radiation and Medical Oncology, Hadassah University Hospital, Jerusalem, Israel. 

1982 - 1983 - Dr. David Edelman: Thesis on Systemic Therapy of Small and Non Small Cell lung cancer. Department of Radiation and Medical Oncology, Hadassah University Hospital, Jerusalem, Israel

1983 - 1985 - Dr. Mahafsah Mahmoud: Ph.D Thesis on Immunologic and humoral effects of a Prostaglandin-Leukotriene Inhibitor (Sodium Meclofenemate). Roswell Park Memorial Institute, Buffalo, NY.

1986 - 1987 - Dr. Daniel Melewski: Post doctoral work on Functional and Morphological Studies of Antitumor Cytotoxic Cells on In Vitro Irradiation Models. Roswell Park Memorial Institute, Buffalo, NY.

1995 - 1997 - Dr. Lida Radfar Post Graduate Study on : An Improved Model for Irradiation-Induced Salivary Gland Injury: A functional and Morphological Study Using the Minipig. UMDNJ, Newark., NJ.

Major Committee Assignments

  • Chairman, Tumor Board, Brooklyn VA Medical Center, 1993 - 1995.
  • Director, Tumor Board, University Hospital, NJ Medical School, Newark NJ.
  • Cancer Liaison Physician, University Hospital, NJ Medical Sсhool, Newark NJ.

Hospital Appointments

  • M.D.Anderson Hospital, Houston. TX 
    Sen. Clinical Fellow, Radiotherapy Dept., 1987 - 1988
  • SUNY Health HSCB
    Attending Physician Dept, of Radiation Oncology, 1991 - 1995
  • Brooklyn V.A. Medical Center Director,
    Division of Radiation Oncology, 1992 - 1995
  • Peninsula Hospital Center, Far Rockaway. NY
    Director, Department of Radiation Oncology, 1994 - 1995

Principal Clinical and Hospital Service Responsibilities

  • Director of Radiation Oncology,
    Lincoln Medical Center,
    Bronx NY
  • Director of Radiation Oncology
    UMDNJ-University Hospital,
    Newark, NJ, 1995 - 1998
  • Chief of Radiation Oncology Service
    Brooklyn VA,
    1992 - 1995
  • Associate Chief of Radiation Oncology Unit Rambam Hospital,
    Haifa, Israel,
    1988 - 1989

Bibliography

  • Naparstek E, Halpern J, Hershko C: Time Related Increase in Leukocyte Yields by Continuous-flow Centrifugation (DFC) Leukophoresis. Scan. J. Haematol. 19:79-84, 1977.
  • Brufman G, Halpern J, Beran S: Combination Chemotherapy for Advanced Lung Carcinoma. J. U.I.C.C. 1189-1191,1979.
  • Halpern J, Brufman G, Schnider B, Beran S: Vinblastine Cyclophosphamide and 5- Fluorouracil (VCF) Combination Chemotherapy for Metastatic Hypernephroma. Oncology 38:193-194,1981.
  • Halpern J, Catane R, Beran S, and Fuks Z: DTIC and Actinomycin D. With and Without C-Parvum Immunotherapy in Advanced Malignant Melanoma. Tumori, 67:215- 217,1981.
  • Halpern J, Catane R, Sachs T. and Fuks Z: The treatment of the Febrile Granulocytopenic Patient Receiving Antineoplastic Therapy: Management with Antibacterial Triad Including Carbenicillin Cefazolin and Gentamicin. J. of Medicine. 14:193-201,1983.
  • Halpern J, Kopolovic J, and Catane R: Malignant Fibrous Histiocytoma (MFH) Developing in Irradiated Sacral Chordoma. Cancer, 53:2661-2662,1984.
  • Halpern J, Gamliel H, Okon E, and Pollack A: Human Peripheral Blood Mononuclear Cells Cultured in Serum Free Medium. A Morphological and Functional Study, J. Med. 15:1-13,1984.
  • Brufman G, Halpern J, Sulkes A, Brian S, and Catane R: Systemic Chemotherapy with Procarbazine, CCNU and Vincristine (PCV) in Brain Tumors. Oncology, 4:239-241, 1984.
  • Halpern J, Catane R: Oral Esdramustine Phosphate (Estracyt). A Broad Phase II Study. J. Med. 15:35-42,1984.
  • Ambrus J, Ambrus C, Halpern J, and Gastpar H: Effect of Second Tumors and Prostaglandin-leukotrein inhibitors on Radiation Therapy of Transplanted Rodent Tumors. J. Med. 15:93-103,1984.
  • Halpern J, Catane R. Baerwald H: A Call for Caution in the Use of Aminoglutethimide: Negative Interactions With Dexamethasone and Beta Blocker Treatment. J. Med. 15:59-63,1984.
  • Halpern J, Kishel S, Park J, Tzukada Y, Johnson R, Ambrus J: Radiation induced Brain Edema in Primates: Studies With Sequential Brain CT Scanning and Histopathology: Protective Effect of Sodium Meclofenamate-A Preliminary Report. Research Comm Chem Path Pharm. 45:463-470,1984.
  • Yablonski, Perez Y, Halpern J, Sulkes A, Fuks Z, Catane R: Small Cell Lung Cancer. Harefuah, 106:450-453,1984.
  • Halpern J, Ambrus J, Ambrus C, Pickren J, Klein E: Effect of Sodium Meclofenamate on Ultraviolet Irradiation Induced Carcinogenesis. J. Med. 15:161-167,1985.
  • Halpern J, Baerwald H, Johnson R, Takita H: A Case of Darvocet Related Radiation Induced Pneumonitis. Arch Int Med. 145:1509-1510,1985.
  • Halpern J, Joy J, Ambrus J: Peripheral Blood Mononuclear Cells Cultured in Serum- free Medium II: Lymphocyte-Macrophage Interactions and Related Morphological Changes. J. Med. 16:461-482,1985.
  • Halpern J, Baerwald H, Johnson R, Ambrus J: Evaluation of Topically Applied L-Aminoethyl-iso-thiouronium (AET) for Radiation Protection of the Skin. A Preliminary Study in Pigs. Res Comm Chem Pathol Pharmacol, 49:47-56,1985.
  • Halpern J, Sofinsky SJ, Fornatch P, Khilchenco S, Ambrus JL: Choroidal Metastases Arising From Carcinoma of the Breast. A Review and Analysis of Five Cases. J. Med. 17:1-11,1986.
  • Ambrus JL, Halpern J, Baerwald H, Johnson R: Cyclooxygenase and Lipoxygenase Inhibitors may Substitute Steroid Treatment in Brain Edema. Lancet, 148-149, July 20, 1985.
  • Halpern J, Pierce J: An Improved Technique for Interstitial Breast irradiation. J. Amer Assoc Med Dosim. 6:37-39,1986.
  • Ambrus JL, Halpern J, Stoll H: Meclomen Potentiates Dermatologic Effects of Steroids. Arch Int Med. 146:1451,1986.
  • Halpern J, Bielat K, Ambrus JL: Human Peripheral Blood Mononuclear Cells Cultured in Serum-free Medium III: Morphological Study of An In Vitro MicrocytotoxicityModel. J. Med. 17:(No 3 & 4):201-208,1986.
  • Ambrus JL, Rasis MD, Bardos TJ, Stadler S, Halpern J, Rasis BA, Gastpar H: Methodology and Ethics of New Types of Cancer Therapy. Adoptive Immunotherapy. Differentiation Inducing Antigens, Lymphokine Releasers, Radiation Potentiators and Protectors. Medical Ethics and/or Ethical Medicine p.88-99,1989.
  • Ambrus CM, Halpern J, Mahafsah M, Rasis BA, Ambrus JL: Ethics and methodology ofStudies on Major Complications in Cancer Patients: Infectious Complications, Thromboembolism, Hypercalcemia and Osteoporosis. Medical Ethics and/or Ethical Medicine p. 99-105,1989.
  • Halpern J, Ambrus JL: Radiobiologic Modifying Agents in Radiation Therapy. Cancer comm. 1:49-84,1987.
  • Piver MS, Marchetti DL, Patton T, Halpern J, Driscoll DL: Radical Hysterectomy and Lymphadectomy vs. Radiation Therapy for Small (Less Then 3 cm) Stage IB Cervical Carcinoma. Am J Clin Oncol. 11:21-24,1987.
  • Bielat KL, Halpern J, J Simich JP, Hubem RP, Ambrus JL: A Morphological Analysis of an In Vitro Model of Cytotoxic Anti-tumor Activity. Cancer Detect Prev.l3:l-7,1988.
  • Halpern J, Islam A, Simich JP, Bielat KL: Tumor Infiltrating Lymphocytes. In Vitro Characterization of Morphological and Phenotypical Changes. Cancer Detect Prev. 13:1- 7,1988.
  • Halpern J, Bielat KL, Simich JP, Ambrus JL: Ultrastructural Descriptions of Interactions Between Tumor Infiltrating Lymphocytes and Tumor Cells in An In Vitro Model of Culture in Serum-free Medium. Cancer Detect Prev. 13:213-223,1988.
  • Ambrus JL, Halpern J, Bardos T, Chmielewitz ZF, Klein E: Radiation Sensitizing and Radiation Protective Agents in Experimental Radiation Therapy. J Med, 19:369-381,1988.
  • Mahafsah M, Halpern J, Nava HR, Huben RP, Bryson W, Sayid S, Ambrus JL: Radioprotective Effect of Sodium Meclofenamate: A Prospective Clinical Trial. J Med 20(3&4):261-272,1989.
  • Halpern J, McNeese MD, Kroll SS, Ellebrock N: Irradiation of Prosthetically Augmented Breasts: A Retrospective Study on Toxicity and Cosmetic Results. Int J Radiat Oncol Biol Phys. 18:189-191,1990.
  • Halpern J, Henkelman G, Maor M, McNeese MC: Locally Advanced Breast Cancer Treated with Neutron Bemas. Long Term Follow-up in 28 Patients. Int J Radiat Oncol Biol Phys 18:825-831,1990.
  • Stein M, Fried G, Borovik R, Halpern J, Beck D, Robinson E.: Malignant melanoma occurring during pregnancy: A report of the Northern Israel Oncology Center. Surg. Oncol 45:117-120,1990.
  • Ambrus JL, Halpern J, Mahafsah M, Sayyid S: Platelet Aggregation in Septic Shocks: Effect of Pentoxifylline. J. Med. 21:121-129,1990.
  • Chadha KC, Ambrus JL, Halpern J, Khalil M, Sayyid S, Piver MS, Hreschchyshin, MM: The Interferon System in Gynecologic Cancer: Effects of Irradiation and Chemotherapy. Cancer 67:87-90,1991.
  • Stein M, Fried G, Burovik R, Halpern J, Beck D, Robinson E: Malignant Melanoma Occurring During Pregnancy. J Surg. Oncol, 47, 221-224,1991.
  • Halpern J, Beny A, Cohen E, Mekori T, Kuten A, Robinson E: The Influence of Ionizing Irradiation on In Vitro Human NK cell Activity. J Med. 22:243-253,1991.
  • Stein M. Kuten A, Halpern J, Cohen Y, Robinson E: The Value of Postoperative Irradiation in Renal Cell Cancer: A Retrospective Study in 147 Patients. Radiotherapy and Oncology 24:41-44,1992.
  • Kuten A, Hilu F, Halpern J, Stein M, Robinson E: Primary breast cancer conservation therapy. Harfuah J of Isr. Med. Assoc 122:409-413,1992.
  • Bielat KL, Simich JP, Ambrus JL, Halpern J, Donahue TM: Ultrastructural and Phenotypic Analysis of Human Antitumor Cytotoxic Lymphocytes in An In Vitro Model as Revealed by Flow Cytometry and Immunogold Labeling. Cancer Detect Prev. 1993.
  • Rotman M, Aziz H, Halpern J, Schwartz D, Sohn C, Choi K: Endometrial carcinoma: Influence of prognostic factors on radiation management. Cancer 71:1471-1479,1993.
  • Aziz H. Rotman M, Hussain F, Smith G, Chan E, Choi K, Sohn C, Halpern J, Schwartz D, Aral I, Fruchter R, Serur E: Poor survival in black patients with carcinoma of the endometrium. Int. J Radiat Oncol Biol Phys. Vol 27(4), 293-301, 1993.
  • Cathcart CS, Dunican A, Halpern JN: Patterns of delivery of Radiation Therapy in an Iner-City Population with Head and Neck Cancer Patients: an analysis of compliance and end results. Accepted for publication, Journal of Medicine, 1996.
  • Halpern JN: The Value of Chest CT in the work-up of Head and Neck Cancer Patients. Accepted for publication, J Med, 1997.
  • Halpern JN: Radiation Therapy in Skin Cancer; a Historical Perspective and Current Applications: Accepted for publication, Dermatol Surg 23:1089-1093, 1997.
  • Anderson J, Halpern JN, Lee D, Rudd J. Peristomal seeding after percutaneous endoscopic feeding tube placement in locally advanced head and neck cancers. Submitted to Cancer, 1997.

Books, Monographs And Chapters

  • Ambrus JL, Rasis MD, Bardos TJ, Stadler S, Halpern J, Rasis BA, Gastpar H: Methodology and Ethics of New Types of Cancer therapy. Adoptive Immunotherapy. Differentiation Inducing Antigens, Lymphokine Releasers, Radiation Potentiators and Protectors, p 88-99, In Medical Ethics and/or Ethical Medicine. Rasis, MD. ed. 1989.
  • Ambrus CM, Halpern J, Mahafsah M, Rasis BA, Ambrus JL: Ethics and Methodology of Studies on Major Complications in Cancer Patients: Infectious Complications, Thromboembolism, Hypercalcemia and Osteoporosis, p 99-105. In Medical Ethics and/or Ethical Medicine. 1989.
  • Halpern J, Maor M: Radiotherapy in the Pediatric Oncology patient p. 62-71. In Handbook of Pediatric Oncology. Gottlieb RA, Pinkel D. Eds. Little Brown & Co. 1989.
  • O'Brien KP, Weisgrau RA, Beck CT, Halpern J: Hodgkin's Disease, p 11-15. In Handbook of Pediatric Oncology. Gottlieb RA, Pinkel D Eds. Little Brown & Co. 1989.
  • O'Brien KP, Weisgrau RA, Black CT, Halpern J: Wilm's Tumor, p 20-23. In Handbook of Pediatric Oncology. Gottlieb RA, Pinkel D Eds. Little Brown & Co, 1989.
  • Hudson MH, Black T, Halpern J: Rhabdomyosarcoma, p 26-29. In Handbook of Pediatric Oncology. Gottlieb RA, Pinkel D Eds. Little Brown & Co. 1989.
  • Jorgensen KF, Weisgrau RA, Halpern J: Ewing Sarcoma p31-34. In Handbook of Pediatric Oncology, Gottlieb RA, Pinkel D Eds. Little Brown & Co. 1989.
  • Maria BL, Halpern J: Increased Intracranial Pressure, p 31-34. In Handbook of Pediatric Oncology, Gottlieb RA, Pinkel D Eds. Little Brown & Co. 1989.
  • Gottlieb RA Halpern J: Spinal Cord Compression p. 166-168. In Handbook of Pediatric Oncology, Gottlieb RA, Pinkel D Eds. Little Brown & Co. 1989.
  • Halpern J: Meningeal Carcinomatosis p 168. In Handbook of Pediatric Oncology, Gottlieb RA, Pinkel D Eds. Little Brown & Co. 1989.
  • Ambrus, JL, Ambrus CM, Forgash P, Stadler S, Halpern J, Sayyid S. Niswander P and Toumbis, C: Studies in tumor induced angiogenesis, p 436-444. In Angiogenesis: kev principles. Science Technology, Medicine. Steiner R, Weisz PB, Langer R, eds. Bickhauser Verlag Basel, Switzerland, 1992.

Abstracts

  • Halpern J, Shapiro M, Catane R, Shnider B, Sachs T, and Fuks Z: Antibiotic therapy of Febrile Patients with Solid Tumors and Chemotherapy induced Leukopenia. Proc. Am. Soc Clin. Oncol. 21, 475, 1980.
  • Halpern J, Catane R, Sulkes A, Brufman G, Rizel S, Ge E, Weshler Z, Biran S, and Fuks Z: Combination Chemotherapy in Non-small Cell Carcinoma of the Lung. Proc. 2nd World Cont. on Lung Cancer, Copenhagen, 1980. P131.
  • Halpern J, Catane R, Beran S, Fuks Z. and Bruftnan G: Chemoimmunotherapy of Melanoma. Proc 2nd Mediterranean Congress of Chemotherapy, 318.1980.
  • Halpern J, Brufman G, Schnider and Brian S: Combination Chemotherapy for Metastic Hypernephroma. Proc,. 2nd Mediterranean Congress of Chemotherapy, 318,1980.
  • Halpern J, Catane R, Sulkes A, Bruftnan G, Ritzel S. Weshler Z, Brian S. and Fuks A: Combination Chemotherapy in Non-small Cell Carcinoma of the Lung. Abstract of the Inti. World Conf. on Lung Cancer. 11,1980.
  • Catane R, Schlanger S, Gottlieb P, Halpern J, Treves AJ, Fuks Z, and Fridkin M: Toxicity and Antitumor Activity of Tuftsin in Mice. Proc. Am. Soc. Clin Oncol.22, 371, 1981.
  • Halpern J, Catane R, Treves AJ and Fuks Z: Peripheral Blood Mononuclear Cells Cultured in Serum Free Medium. Proc lsr. Soc. Immunol. 1982.
  • Catane R. Treves AJ, Weiss L, Levy F, Halpern J, Sulkes A, Fuks A, and Fridkin M: Clinical Phase I Study of Tuftsin, ASCO, 1983. Proc. Am. Soc. Clin. One. 2:45,1983.
  • Halpern J, McAuley M, Pearce J, Johnson R: An Improved Technique for Interstitial Breast Irradiation. Int J Rad One Biol Phys. 10:(2), 178,1984.
  • Halpern J, Kishel S, Johnson R, Ambrus J: Radiation Induced Brian Edema in Primates. Studied Sequential Brain CAT Scanning and Histopathology. Protective Effect of Sodium Meclofenamate Seventh Ann. Mtg. American Society of Primatologists. Niagara Falls, NY June, 1985
  • Baerwald H, Halpern J, Johnson R, Ambrus J: Protective Effect of Sodium Meclofenamate on Radiation Induced Esophagitis and Cystitis. Seventy Ann. Mtg. Amer. Soc Primatologists. Niagara Falls, NY June, 1985.
  • Halpern J, Ambrus J, Ambrus C, Gastpar: Effect of Sodium Meclofenamate (M) on Ultraviolet B Radiation (UVBR) Induced Carcinogenesis, Amer. Assoc. for Cancer Res, 1985.
  • Halpern J, Mahafsah M, Catane R: Oral Estramustine Phosphate (ESTRACYT): A Broad Phase Study. Proc ASCO, 4:25,1985.
  • Halpern J, Krishnamsetty R, Bahafia S, Kishel S, Johnson R, Ambrus JL: Evaluation of Topically Applied 2-Aminoethyl-iso-thioruronium (AET) for Protection Against Radiation Damage in Pigs Skin. Radiology, 157-97,1985.
  • Halpern J, Mahafsah M, Johnson R, Ambrus J: Protection Effect of Sodium Meclofenamate (SM) in Radiation Induced Brain Edema in Primates. Radiation Res. Soc. 34th Ann. Mtg. p 41,1986.
  • Tjota A, Halpern J, Mahafsah M, Ambrus JL: Effect of the Prostaglandin Leukotriene Inhibitor Meclomen on Alleviating Radiation Induced Mucositis and Carcinogenesis in Radiation Therapy UICC, 1986. Presented.
  • Halpern J, Bielat KL, Ambrus JL: Studies on Adoptive Immunotherapy Using Interferon B (FB) and Interleukin-2 (IL-2). Anticancer Research 6:400,1986.
  • Ambrus JL, Halpern J, Biddle W, Ricci P, Noe M, Belmusto V, Early A, Upson J: Studies on Adoptive Immunotherapy. Proc. AACR, 27:320,1986.
  • Halpern J, Mahafsah M, Ambrus JL,: Protective Effect of Sodium Meclofenamate (SM) for Radiation Induced Mucositis of the Esophagus, Large Bowel and Urinary Bladder. Presented, ASCO 1987.
  • Halpern J, Simich J, Stadler I, Baker T, Bardos TJ, Ambrus JL: Two new radiosensitizers: An In Vitro Study of their Radiation Modifying Effect on Gardner Lymphosarcoma Cells. Proc. AACR 28:433,1987.
  • Bielat KL, Halpern J, Simich JP, Ambrus JL: A Morphological Analysis of an In Vitro Model of Antitumor Activity: Proc ASCO 6:972,1987.
  • Simich JP, Halpern J, Ambrus JL: An In Vitro Model of Antitumor Infiltration Lymphocytes (TIL) and their Significance. Proc FASEB, 46:1512,1987.
  • Ambrus JL, Halpern J, Diberardino LA, Piver MS, Chadha K: Interferon and Interferon Inactivators in Cancer Patients: Changes During Radiation Therapy. Pro. AACR, 28:381, 1987.
  • Marchetti DL, Piver MS, Lele SB, Baker T, Halpern J, Emrich L: Pelvic Radiation therapy Following Surgery in Patients with Stage I Endometrial Carcinoma, Grade 3, or More than 50% Myometrial Invasion. Presented SGO1988.
  • Halpern J, McNeese MD, Kroll S: Cosmesis after Irradiation of Subcutaneous Breast Implants: Long Term Follow-up in Six Patients. Presented ASCO 1988.
  • Halpern J, Henkelman G, Maor M: Neutron Therapy for Locally Advanced Breast Cancer: A Toxicity Study in 28 Patients. Presented ASTRO 1988.
  • Rosenblatt E, Stein M, Epelbaum R, Mandeltzweig Y, Halpern J, Tatcher M, Kuten A: Results of Total Skin Irradiation for Mycosis Fungoides. Presented at the 7th Meeting of The Israeli Medical Assoc. 1989.
  • Halpern J, Stein M. Kuten A, Cohen Y, Robinson E: The Value of Postoperative irradiation in Renal Cell Cancer. Presented at the Meeting of the American RadiumSociety, 1990.
  • Rubinov R. Appelbaum R. Steiner M, Honigman J, Halpern J, Robinson E: Combination Chemotherapy with Methotrexate, Cisplatinum and Velban with Adriamicin (MVAC) or Without Adriamicin (MCV) in Advanced Urinary Malignancies. ASCO proceedings 1990 p. 153.
  • Halpern J, Beny A, Cohen E, Mekori T, Robinson E: The Influence of In Vitro Irradiation on Human NK Cell Activity. Presented at ASTRO 1990.
  • Rosenblatt E, Halpern J, Kuten A, BarDaroma, M: Dose specification in Iridium-192 Interstitial brachytherapy. Presented at the Seminar for Europe, the Middle East and Africa on Radiotherapy and Dosimetry. Lewen, Belgium, September 1991.
  • Halpern J: High Yield of Chest CT Scans in Chest X-Ray Negative Head and Neck Cancer Patients. Proceedings of ASCO, Volume 13:285, 1994.
  • Cathcard C, Halpern J, Lee D, Lehman D, Baredes S, Schulder M: Stereotactic Radiosurgery for Tonsilar Carcinoma. Presented, The Oncology Society of New Jersey Scientific Symposium March 6 1996.
  • Halpern J, Vadula R, Narra V, Manolatos S.: High Incidence of Chronic Anal Stenosis in Prostate Cancer Patients Treated with topical Steroids During Radiation Therapy. Submitted: American Society of Therapeutic and Clinical Oncology, 1996.
  • Cathcard C, Halpern J, Lee D, Lehman D. Baredes S. Schulder M.: Stereotactic Radiosurgery for Tonsilar carcinoma. Presented 3/96 at the Symposium of the Oncology Society of New Jersey and the Academy of Medicine of New Jersey.
  • Narra VR, Cathcart SC, Schulder MD, Hawkins CJ, Halpern JN: Measurements of Fetal Dose in Radiosurgery During Pregnancy; Approaches to Fetal Dose Reduction. AAPM, 1997.
  • Halpern JN, Narra VR, Cathcart CS, Hawkins CJ, Schulder MD: Radiosurgery in Childbearing Age Women; A Study of Pelvic Dose as a Function of Arc Degrees and Couch Angles. Presented at the Annual Retreat on Cancer research in New Jersey, May 30,1997.

Schedule Appointment

* Please fill out required field